Skip to content

Virtual Reality Stimulation to Enhance Cognitive Function of Intensive Care Unit Patients

Virtual Reality Stimulation to Enhance Cognitive Function of Intensive Care Unit Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03025373
Enrollment
67
Registered
2017-01-19
Start date
2017-02-01
Completion date
2019-04-01
Last updated
2019-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Impairment, Mild, Quality of Life

Brief summary

An observational study will be conducted in the ICU (Intensive care unit) including patients with heart surgery (\< 5 days) and prolonged ICU stay (\> 5 days). Patients will receive 5 min Virtual reality stimulation per day. A modified version of the Oculus Rift VR glasses (Facebook inc., USA) with stereoscopic vision and stereo sound will be used to present the virtual world to patients. An integrated eye tracker will measure oculomotor responses that will be synchronized with the physiological data recording. All participants will undergo neuropsychological testing after ICU stay, and after a three-months follow-up. Quality of life prior to the ICU stay will be enquired from relatives. Main outcome variable is the explorative behaviour (attention). Secondary outcomes are the quality of life and cognitive functioning.

Interventions

OTHERVisuo-acoustic stimulation

Controlled visual and acoustic stimulation in a virtual reality setting

Sponsors

University of Bern
CollaboratorOTHER
Insel Gruppe AG, University Hospital Bern
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age \> =18 * Speak German or French * Are able to participate the follow up measurements * Written informed consent

Exclusion criteria

* Visual impairments * Cognitive impairments * Cognitive impairments * Craniocerebral injury before admitting the ICU * Already admitted the intensive care unit (last year) or at reentry * Psychotic disorders

Design outcomes

Primary

MeasureTime frameDescription
Attention measurement in patients in the intensive care unitChanges from baseline in attention measurement during and after admission (3 Month) to the ICUThe attention is measured via explorative behaviour of the subject. This means an eye tracker is used to measure eye movements, fixation duration and number of fixations, which can be used to calculate the explorative behaviour.

Secondary

MeasureTime frameDescription
Quality of LifeAfter 3 months after admission to the ICUThe quality of life are examined via EuroQol (EQ-5D-5L) questionnaire
Cognitive functioningChanges from baseline in cognitive functioning measurement after admission (3 Month) to the ICUThe cognitive abilities are examined via CERAD test battery (Consortium to Establish a Registry for Alzheimer's Disease) this includes word fluidity, Boston Naming Test (BNT), mini-mental state examination (MMSE), word list memory, constructive practice, word list retrieve, word list recognition, constructive practice (retrieve)

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026